The Arab American News Though there is no cure for multiple myeloma, Andrew Kin, M.D. , hematologist and medical oncologist, and member of the Bone Marrow & Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, described how survival rates have improved due to treatment advances. Dr. Kin explained that data shows this most common type of blood cancer is more prevalent in some populations than othe...
Patient Power Smoldering multiple myeloma (SMM) is believed to be a precancer that can develop into multiple myeloma. Andrew Kin, M.D. , hematologist and medical oncologist, and member of the Bone Marrow and Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, said the genetic basis of how smoldering multiple myeloma and multiple myeloma begins is still being researched. Dr. Kin discussed the potential risk fac...
Patient Power Investigators are studying the cancer risks related to high and low Immunoglobulin A (IgA) levels. Andrew Kin, M.D. , hematologist and medical oncologist, and member of the Bone Marrow & Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, discussed what certain levels of IgA may indicate, including conditions other than cancer. Read the article here .